Key result
Everyday smoking among stable schizophrenia outpatients drops ~31% over eleven years.
Cohort (n=102)
No
Absolute Event Rate: 43.3% vs 63.2%
p-value: p=<.001
Smoking prevalence can be significantly reduced over time in stable outpatients with schizophrenia.
Decline in smoking among schizophrenia outpatients supports cessation monitoring; leaves open drivers and need for prospective trials.
Objectives: Despite the well-documented link between high rates of smoking and schizophrenia, there have been no longitudinal studies that have looked at rates of smoking and associated factors over time. This prospective study examined the longitudinal rates of smoking in a schizophrenia clinic sample over a decade. Design: Longitudinal survey research. Setting: A well-established community-based psychiatric rehabilitation program in Hamilton, Ontario, Canada providing long-term intensive case management and rehabilitation skills training. Participants: Stable community outpatients diagnosed with schizophrenia were surveyed initially in 1995 (N = 102) and then re-surveyed eleven years later in 2006 (N = 76). Main Outcome Measures: Self-report of smoking status. Results:Smoking rates dropped significantly over time, with evidence that the number of ‘quitters’ tripled over the past decade and the number of ‘everyday’ smokers decreased by almost a third from 63.2% down to 43.3% (p < .001). Conclusions: The findings from the present study suggest that it is possible to obtain reduced smoking prevalence over time in a selected schizophrenia outpatient sample, though further research is required to better understand the factors related to quitting smoking in individuals with schizophrenia.
No takes yet. Share an insight, caveat, or question.
Leslie Samuel (1995) conducted a cohort in Schizophrenia (n=102). Time vs. Baseline was evaluated on Self-report of smoking status (everyday smokers) (p=<.001). The prevalence of everyday smoking in stable community outpatients with schizophrenia decreased significantly over an 11-year period from 63.2% to 43.3% (p < .001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: